Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and omecamtiv mecarbil

moxifloxacin has been researched along with omecamtiv mecarbil in 1 studies

Compound Research Comparison

Studies
(moxifloxacin)		Trials
(moxifloxacin)		Recent Studies (post-2010)
(moxifloxacin)		Studies
(omecamtiv mecarbil)		Trials
(omecamtiv mecarbil)		Recent Studies (post-2010) (omecamtiv mecarbil)
3,1575521,69015224143

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abbasi, S; Brooks, A; Darpo, B; Dutta, S; Flach, S; Hsu, CP; Israel, S; Jafarinasabian, P; Lee, E; Terminello, B; Trivedi, A; Xue, H; Zhang, H1

Trials

1 trial(s) available for moxifloxacin and omecamtiv mecarbil

ArticleYear
Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrations.
    British journal of clinical pharmacology, 2022, Volume: 88, Issue:1

    Topics: Cross-Over Studies; Double-Blind Method; Electrocardiography; Fluoroquinolones; Heart Rate; Humans; Moxifloxacin; Urea

2022